Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Platelet-rich plasma injections for joint and tendon problems

Official title: Platelet Rich Plasma for Musculoskeletal Conditions

Run by University of Utah · NCT07231471 · Data updated 2026-11-12

This project will test whether platelet-rich plasma (PRP) injections help people with osteoarthritis and other musculoskeletal conditions reduce pain and improve function over one year.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedDecember 29, 2025
Main results expectedJanuary 1, 2035
Study endsJanuary 1, 2035
Registry record updatedMay 6, 2026
Trial IDNCT07231471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with musculoskeletal pathology that may benefit from a PRP injection who have failed other conservative treatments are ideal candidates, provided they have no active infection, malignancy, platelet disorder, or need for dialysis.

Probably not a fit

Patients with active infection at the injection site, active malignancy, known platelet disorders, those on dialysis, or people with conditions unlikely to respond such as very advanced joint destruction may not receive benefit from PRP in this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who receive PRP injections for a variety of musculoskeletal conditions will be enrolled in a registry and followed for 12 months. Standardized outcomes for pain, physical function, and overall patient satisfaction will be collected at scheduled intervals. The registry includes patients treated for knee, hip, shoulder, ankle, elbow, sacroiliac joint issues and common tendinopathies. Data on injection preparation, safety events, and prior conservative treatments will also be recorded to help characterize real-world effectiveness.

Why it matters

Potential benefit: If successful, this work could help demonstrate that PRP offers meaningful pain relief and functional improvement with lower risk than repeat corticosteroid injections, guiding treatment choices for people with MSK conditions.

How similar studies have gone: Previous randomized trials and systematic reviews, especially in knee osteoarthritis and several tendinopathies, have shown PRP to be equal or superior to corticosteroids and hyaluronic acid for pain and function.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18+ years old
* Musculoskeletal pathology that may benefit from a PRP injection
* Failed other conservative treatments

Exclusion Criteria:

* No active malignancy
* No active infection in the area of injection
* No platelet disorder
* No active systemic infections
* No patients currently undergoing dialysis

Where it's running

  • University of Utah Orthoaedic Center
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.